Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$84.31
-1.4%
$82.32
$73.31
$120.30
$210.88B0.3715.21 million shs6.62 million shs
Steelcase Inc. stock logo
SCS
Steelcase
$16.81
+0.2%
$13.14
$9.31
$17.13
$1.93B1.261.12 million shs976,083 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
+1.44%+0.24%+7.66%+9.02%-27.95%
Steelcase Inc. stock logo
SCS
Steelcase
+0.06%+0.84%+65.17%+61.51%+18.56%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
4.9971 of 5 stars
3.24.05.04.23.01.73.8
Steelcase Inc. stock logo
SCS
Steelcase
4.0208 of 5 stars
1.05.02.52.03.22.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.35
Hold$107.4427.43% Upside
Steelcase Inc. stock logo
SCS
Steelcase
2.00
Hold$16.00-4.79% Downside

Current Analyst Ratings Breakdown

Latest WRKS, STU, SCS, and MRK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/5/2025
Steelcase Inc. stock logo
SCS
Steelcase
Noble Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/30/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$97.00 ➝ $90.00
7/10/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$99.00 ➝ $98.00
(Data available from 9/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$63.62B3.31$9.48 per share8.89$19.64 per share4.29
Steelcase Inc. stock logo
SCS
Steelcase
$3.17B0.61$1.88 per share8.92$8.37 per share2.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$17.12B$6.4913.018.520.8925.79%41.05%16.55%10/30/2025 (Estimated)
Steelcase Inc. stock logo
SCS
Steelcase
$120.70M$1.0316.3315.851.593.84%14.49%6.00%9/17/2025 (Estimated)

Latest WRKS, STU, SCS, and MRK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/17/2025Q2 2026
Steelcase Inc. stock logo
SCS
Steelcase
$0.37N/AN/AN/A$878.73 millionN/A
7/29/2025Q2 2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$2.03$2.13+$0.10$1.76$15.92 billion$15.81 billion
6/25/2025Q1 2026
Steelcase Inc. stock logo
SCS
Steelcase
$0.12$0.20+$0.08$0.11$759.90 million$779.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.243.84%N/A49.92%14 Years
Steelcase Inc. stock logo
SCS
Steelcase
$0.402.38%N/A38.83%N/A

Latest WRKS, STU, SCS, and MRK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/22/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
quarterly$0.813.97%9/15/20259/15/202510/7/2025
6/25/2025
Steelcase Inc. stock logo
SCS
Steelcase
quarterly$0.103.6%7/7/20257/7/20257/21/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.69
1.42
1.17
Steelcase Inc. stock logo
SCS
Steelcase
0.46
1.65
1.15

Institutional Ownership

CompanyInstitutional Ownership
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
76.07%
Steelcase Inc. stock logo
SCS
Steelcase
92.42%

Insider Ownership

CompanyInsider Ownership
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.13%
Steelcase Inc. stock logo
SCS
Steelcase
6.75%
CompanyEmployeesShares OutstandingFree FloatOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
75,0002.50 billion2.50 billionOptionable
Steelcase Inc. stock logo
SCS
Steelcase
11,300114.64 million106.90 millionOptionable

Recent News About These Companies

Hsbc Holdings PLC Has $1.28 Million Stake in Steelcase Inc. $SCS
Nuveen LLC Purchases New Shares in Steelcase Inc. $SCS
Invesco Ltd. Has $3.26 Million Holdings in Steelcase Inc. $SCS
3 Services Stocks We’re Skeptical Of
Steelcase Completes Stock Conversion Amid HNI Merger
HNI And Steelcase: Doubling Down On The Office

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Merck & Co., Inc. stock logo

Merck & Co., Inc. NYSE:MRK

$84.31 -1.17 (-1.36%)
As of 03:25 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Steelcase stock logo

Steelcase NYSE:SCS

$16.80 +0.04 (+0.21%)
As of 03:25 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Steelcase Inc. provides a portfolio of furniture and architectural products and services in the United States and internationally. It operates through Americas and International segments. The company's furniture portfolio includes furniture systems, seating, storage, fixed and height-adjustable desks, benches, and tables, as well as complementary products, such as work accessories, lighting, mobile power, and screens. Its seating products comprise task chairs; seating for collaborative environments and casual settings; and specialty seating for specific vertical markets, including education and healthcare. The company's interior architectural products comprise full and partial height walls and architectural pods. It also provides textiles and surface imaging products for architects and designers; and workplace strategy consulting, lease origination, and furniture and asset management services. The company markets and sells its products to corporate, government, healthcare, education, and retail customers under the Steelcase, AMQ, Coalesse, Designtex, HALCON, Orangebox, Smith System, and Viccarbe brands. It distributes its products and services through a network of independent and company-owned dealers, as well as directly to end-use customers. The company was incorporated in 1912 and is headquartered in Grand Rapids, Michigan.